| Abstract: |
Most patients diagnosed with differentiated thyroid cancer have a low-risk of recurrence. The recommendations for long-term surveillance should reflect the low-risk nature of this disease. Suppressive doses of thyroid hormone are generally not needed in patients with low-risk thyroid cancer. In addition, the less frequent thyroid ultrasound monitoring and thyroglobulin measurement may be appropriate. As there is no survival benefit to long-term surveillance in patients with low-risk thyroid cancer, the timing and frequency of monitoring should reflect the natural history of low-risk differentiated thyroid cancer, meaning that the risk for recurrence is low. © The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2023. |
